Federica Martini
About Federica Martini
Federica Martini is a Regulatory Affairs Manager at Abeona Therapeutics Inc., where she has worked since 2017. She has a background in regulatory affairs and pharmacovigilance, with previous roles at INIA, Rovi CM, and Sermes CRO.
Work at Abeona Therapeutics
Federica Martini has been serving as the Regulatory Affairs Manager at Abeona Therapeutics Inc. since 2017. In this role, she is responsible for overseeing regulatory compliance and ensuring that the company's products meet all necessary regulatory standards. Her work involves collaborating with various departments to facilitate the approval process for new therapies and maintaining ongoing compliance with regulatory requirements.
Previous Experience in Regulatory Affairs
Prior to her current position, Federica Martini worked at several organizations in the field of regulatory affairs and quality management. She was employed at Sermes CRO as a Quality and Documentation Technician from 2014 to 2017. Before that, she held a position at Rovi CM in pharmacovigilance for a brief period in 2012. Her early career included roles at INIA, where she worked as a researcher from 2008 to 2012 and as a technology intern from 2005 to 2007.
Education and Expertise
Federica Martini has a solid educational background in the field of life sciences. She studied at Universidad Complutense de Madrid from 2005 to 2007, where she completed her undergraduate studies. She furthered her education at Universidad Autónoma de Madrid, earning a Master's degree from 2011 to 2012. Additionally, she attended Universidad Complutense de Madrid in 2014 for a short period, enhancing her knowledge in regulatory affairs.
Career Timeline
Federica Martini's career spans various roles in regulatory affairs and research. She began her professional journey as a technology intern at INIA from 2005 to 2007, followed by a research position at the same institution until 2012. After a brief stint in pharmacovigilance at Rovi CM in 2012, she worked at Sermes CRO from 2014 to 2017 before joining Abeona Therapeutics. Her diverse experiences contribute to her expertise in regulatory affairs.